CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Data as of , from SEC Form 4 filings.
See up to 3 months of CYPH. The 7-day demo opens the 1M and 3M ranges and puts CYPH on your watchlist.
Start 7-day demoLatest CYPH insider trades
About CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
- CAMBRIDGE, MA
- 6
- 2014
- XNAS
CYPH Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 238,750 | $889K |
| Grant or award | 1 | 2,000,000 | |
| Other acquisition / disposition | 6 | 152,863,492 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CYPH insider transactions (Form 4)
3765 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Christian M. Richard - Director | Grant or award | Restricted Stock Units | 74,700 | $0.00 | - | |
| Nissim Mashiach - Director | Grant or award | Restricted Stock Units | 74,700 | $0.00 | - | |
| Patricia A. Martin - Director | Grant or award | Restricted Stock Units | 74,700 | $0.00 | - | |
| Richard Schilsky - Director | Grant or award | Restricted Stock Units | 74,700 | $0.00 | - | |
| Joseph Loscalzo - Director | Grant or award | Restricted Stock Units | 74,700 | $0.00 | - | |
| Thomas John Dietz - Director | Grant or award | Restricted Stock Units | 83,000 | $0.00 | - | |
| Khing Djien Oei - Director | Grant or award | Restricted Stock Units | 74,700 | $0.00 | - | |
| Khing Djien Oei - Director | Grant or award | Restricted Stock Units | 2,411,700 | $0.00 | - | |
| Douglas E. Onsi - Officer | Grant or award | Restricted Stock Units | 2,087,287 | $0.00 | - | |
| Christopher Mirabelli - Director | Grant or award | Restricted Stock Units | 74,700 | $0.00 | - | |
| James H. Cavanaugh - Director | Grant or award | Restricted Stock Units | 74,700 | $0.00 | - | |
| Douglas E. Onsi - Officer | Option exercise | Common Stock | 32,500 | - | - | |
| Douglas E. Onsi - Officer | Option exercise | Restricted Stock Units | 32,500 | $0.00 | - | |
| Augustine Lawlor - Officer | Option exercise | Common Stock | 22,500 | - | - | |
| Augustine Lawlor - Officer | Tax withholding / forfeiture | Common Stock | 7,797 | $0.32 | $2K | |
| Augustine Lawlor - Officer | Option exercise | Restricted Stock Units | 22,500 | $0.00 | - | |
| Christopher Mirabelli - Officer | Option exercise | Common Stock | 22,500 | - | - | |
| Christopher Mirabelli - Officer | Tax withholding / forfeiture | Common Stock | 6,672 | $0.32 | $2K | |
| Christopher Mirabelli - Officer | Option exercise | Restricted Stock Units | 22,500 | $0.00 | - | |
| Douglas E. Onsi - Officer | Other | Common Stock | 2,136 | $2.82 | $6K | |
| Douglas E. Onsi - Officer | Other | Warrant (Right to Buy) | 2,136 | $0.00 | - | |
| Augustine Lawlor - Officer | Other | Common Stock | 2,136 | $2.82 | $6K | |
| Augustine Lawlor - Officer | Other | Warrant (Right to Buy) | 2,136 | $0.00 | - | |
| Christopher Mirabelli - Officer | Other | Common Stock | 2,136 | $2.82 | $6K | |
| Christopher Mirabelli - Officer | Other | Warrant (Right to Buy) | 2,136 | $0.00 | - | |
| James H. Cavanaugh - Director | Other | Common Stock | 213 | $2.82 | $601 | |
| James H. Cavanaugh - Director | Other | Warrant (Right to Buy) | 213 | $0.00 | - | |
| Christine Granfield - Officer | Grant or award | Employee Stock Option (Right to Buy) | 85,000 | $0.00 | - | |
| Cynthia Sirard - Officer | Grant or award | Employee Stock Option (Right to Buy) | 85,000 | $0.00 | - | |
| Richard Schilsky - Director | Grant or award | Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| Christian M. Richard - Director | Grant or award | Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| Patricia A. Martin - Director | Grant or award | Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| John Mark O'Mahony - Officer | Grant or award | Employee Stock Option (Right to Buy) | 85,000 | $0.00 | - | |
| Thomas John Dietz - Director | Grant or award | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Jason Baum - Officer | Grant or award | Employee Stock Option (Right to Buy) | 85,000 | $0.00 | - | |
| Nissim Mashiach - Director | Grant or award | Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| Joseph Loscalzo - Director | Grant or award | Stock Option (Right to Buy) | 25,000 | $0.00 | - |
Recent CYPH Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Dietz Thomas John | Director | 20,000 | $32K | View on EDGAR |
CYPH insider trading FAQ
What is the latest insider trade for CYPH?
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had 6 insider filings in the last 90 days, with the most recent on 2026-09-25. The full record for CYPH runs to 65 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CYPH stock?
No insider purchases of CYPH were filed in the last 90 days.
How many insiders are selling CYPH stock?
3 insider sales of CYPH were filed in the last 90 days, totaling $889K.
Where can I see CYPH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CYPH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Khing Djien Oei view on EDGAR
- - Patricia A. Martin view on EDGAR
- - Thomas John Dietz view on EDGAR
- - Kevin Zhang view on EDGAR
- - William Patrick McEvoy III view on EDGAR
- - Winklevoss Capital Fund, LLC view on EDGAR
- - Christian M. Richard view on EDGAR
- - Khing Djien Oei view on EDGAR
- - Thomas John Dietz view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CYPH's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CYPH with a 7-day demo
- CYPH on your watchlist
- Every CYPH Form 4 filing on record
- Up to 3 months of CYPH price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
